Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors

Core Insights - Picard Medical, Inc. has announced the election of Patrick NJ Schnegelsberg as a member of the Board of Directors of the Arizona Bioindustry Association (AZBio), with his term extending through December 2028 [1][2] Company Overview - Picard Medical is the parent company of SynCardia Systems, which is known for developing the world's first total artificial heart approved by both the U.S. FDA and Health Canada [1][5] - The SynCardia Total Artificial Heart (STAH) is the only commercially available artificial heart in the U.S. and Canada, with over 2,100 implants performed across 27 countries, making it the most widely used and studied artificial heart globally [5] Industry Context - Arizona is recognized as a significant hub for life sciences innovation, with AZBio playing a crucial role in fostering collaboration and growth within the industry [2][4] - The AZBio Association aims to promote the growth of Arizona bioscience companies and serves as a unified voice for the bioscience industry in the state [4]